Six different methods for a-amylase determination were compared by assaying human serum samples covering a wide range of a-amylase values. All the methods studied use as substrate a maltooligosaccharide with a chromophore group at the reducing end; some are chemically blocked at the nonreducing end. Intermethod comparison by regression and correspondence analyses showed significant differences for two methods. The commutability of 12 commercial control materials containing a-amylase was also assessed by the different methods in comparison with human serum specimens containing the pancreatic and salivary isoenzymes. We also studied the behavior of pancreatic and salivary materials prepared in our laboratory. Control materials with a-amylase of nonhuman origin were not commutable with the enzyme in human sera and should not be used for intermethod calibration. 
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Assay temperature was 37#{176}C. The calculation factor was obtained from the sample and reagent volumes, the molar absorptivity of the measured product, and the stoichiometric coefficient; this did not always coincide with that given by the manufacturer, which is often obtained by intermethod calibration. Projection of P and S specimens along factonal axes 1 and 2 (A) and along axes 2 and 3(B). #{149}, control materials projection; +, P-group projection; U, S-group projection. (abbreviationsas in 
Results

Characteristics of the Methods
Lag phase. The incubation time required to allow reading of constant reaction rates was studied with human serum samples containing salivary and pancreatic a-amylase. Methods A, B, and D required >4 mm to reach linearity, methods C and E required --1 mm, and method F showed an almost constant reaction rate from the beginning of the incubation. Precision. Precision was estimated by analyzing pancreatic material as a sample four times on four different days. The most precise method was method C (CV 0
Commutability of Materials
The catalytic concentration of a-amylase was measured by the various methods in the control materials and in the prepared materials containing salivary and pancreatic a-amylase purified from human sources.
Commutability of the materials with the human serum specimens for each couple of methods was judged by comparing the result from one method with the result from the other. The materials were considered commutable if the results were within the 95% confidence region of the respective regression equations. Table 2 summarizes the commutability study. For the majority of methods pairs, only the pancreatic material and the control material Liotrol P were found to be commutable with human sera containing the pancreatic isoenzyme. The behavior of the materials was further studied with correspondence analysis. Calculation of the three factorial axes (1, 2, and 3) obtained by correspondence analysis showed that they account for, respectively, 61%, 14%, and 12% of the total variance of the system. Fig. 1 shows the distribution map of human sera groups S and P, control materials, and pancreatic and salivary materials for axes 1,2, and 3. The projection of two specimens in proximity indicates that they possess a similar intermethod behavior. Axis 1, the most significant axis, describes differences between the behavior of the human a-amylase isoenzymes. Along axis 2 we found a great difference in the projection of specimens with a-amylase of human origin and of nonhuman origin. Separation of specimens according to their a-amylase origin was also observed along axis 3. Several human sera, two from the S group and six from the P group, were clustered in the positive direction along axis 1 and far from the other human sera. Those sera were not commutable for four or more pairs of methods compared, perhaps because of the presence of unknown interferents.
Discussion
The existence of a variety of methods for ct-amylase determination causes a wide interlaboratory dispersion of serum a-amylase activity values (3). The control materials or calibrators used in interlaboratory surveys have different behaviors, depending on the substrate, and usually show lack of commutability. We compared six methods for serum a-amylase determination and studied the commutability of several commercial control materials besides that of pancreatic and salivary materials prepared in our laboratory.
All the studied methods use as substrate a maltooligosaccharide with a chromophore group (4-nitrophenyl or 2-chloro--4-nitrophenyl)
at the reducing end as substrate. Some of the substrates are chemically blocked with an ethylidene (method B), benzylidene (method C), or benzyl (method E) group at the nonreducing end.
Methods
comparison results were very similar for sera containing pancreatic and salivary cz-amylase (Table 1). Methods A, D, E, and F showed similar activities, whereas methods B and C showed somewhat higher activities in sera with salivary a-amylase than in those with the pancreatic isoenzyme, when compared with the results of the other methods. These differences were statistically significant. The results for control materials showed that most of their projections fell outside the cluster determined by human sera. The materials can be classified in three groups: One includes pancreatic and salivary materials, Control Serum P, Lyphocheck 2, and Liotrol P, which were projected near the human sera. A second group contained the remaining control materials except Control Serum II and yielded projections that were close one each other and far from human sera. Control Serum II, the third group, was projected far away from human sera and the other control materials.
Control
In conclusion, only our specially prepared pancreatic and salivary materials and Liotrol P control material were commutable for the majority of methods pairs. Differential sources of a-amylase in control materials can explain the absence of commutability (13) .
Whereas a-amylase in the Liotrol P material was of human origin, the rest of control materials were supplemented with a-amylase from bovine, porcine, or unspecified animal origin. The different behavior of Control Serum II material from human sera and the other control materials was probably due to the microbial origin of its a-amylase. Therefore, control materials supplemented with a-amylase of nonhuman origin are not commutable with the enzyme in human sera and cannot be used for intermethod calibration. Their use in external quality-assessment surveys will provide ratios between methods that will be different from the corresponding ratios involving human sera. The human-source materials most closely mimicked patients' specimens but did not show commutability across all systems evaluated. These materials may be used as intermethod calibrators only for those pairs of methods for which commutability has been demonstrated.
